GeoffreyWolfeKrystalMD

Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Dr. Krystal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1982 - 1985
University of Miami Leonard M. Miller School of MedicineClass of 1982

PubMed

79 citations
Venetoclax is effective in small cell lung cancers with high BCL-2 expression
Timothy L. Lochmann, Konstantinos V. Floros, Mitra Naseri, Krista M. Powell, Wade Cook
Clinical Cancer Research. 2018-01-15
66 citations
Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways.
Chunrong Yu, Mark A. Subler, Mohamed Rahmani, Erin Reese, Geoffrey W. Krystal
Cancer Biology & Therapy. 2003-05-04
117 citations
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer
Anna Rodina, Maria Vilenchik, Kamalika Moulick, Julia Aguirre, Joungnam Kim
Nature Chemical Biology. 2007-08-01

Scientists Work to Bring About a New Treatment for Rare Childhood CancerMarch 7th, 2016
Scientists Pinpoint Protein That Could Improve Small Cell Lung Cancer TherapiesApril 22nd, 2014